https://scholars.lib.ntu.edu.tw/handle/123456789/514039
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | SHU-CHEN WEI | en_US |
dc.contributor.author | Siegmund B. | en_US |
dc.contributor.author | Le Berre C. | en_US |
dc.contributor.author | Ferrante M. | en_US |
dc.contributor.author | Shen B. | en_US |
dc.contributor.author | Bernstein C.N. | en_US |
dc.contributor.author | Danese S. | en_US |
dc.contributor.author | Peyrin-Biroulet L. | en_US |
dc.contributor.author | Hibi T. | en_US |
dc.creator | Taku Kobayashi | - |
dc.creator | Britta Siegmund | - |
dc.creator | Catherine Le Berre | - |
dc.creator | Marc Ferrante | - |
dc.creator | Bo Shen | - |
dc.creator | Charles N. Bernstein | - |
dc.creator | Silvio Danese | - |
dc.creator | Laurent Peyrin-Biroulet | - |
dc.creator | Toshifumi Hibi | - |
dc.date.accessioned | 2020-09-17T08:08:57Z | - |
dc.date.available | 2020-09-17T08:08:57Z | - |
dc.date.issued | 2020 | - |
dc.identifier.issn | 2056-676X | - |
dc.identifier.uri | https://rdcu.be/b7kl8 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/514039 | - |
dc.description.abstract | Ulcerative colitis (UC) is a chronic inflammatory bowel disease of unknown aetiology affecting the colon and rectum. Multiple factors, such as genetic background, environmental and luminal factors, and mucosal immune dysregulation, have been suggested to contribute to UC pathogenesis. UC has evolved into a global burden given its high incidence in developed countries and the substantial increase in incidence in developing countries. An improved understanding of the mechanisms underlying UC has led to the emergence of new treatments. Since the early 2000s, anti-tumour necrosis factor (TNF) treatment has significantly improved treatment outcomes. Advances in medical treatments have enabled a paradigm shift in treatment goals from symptomatic relief to endoscopic and histological healing to achieve better long-term outcomes and, consequently, diagnostic modalities have also been improved to monitor disease activity more tightly. Despite these improvements in patient care, a substantial proportion of patients, for example, those who are refractory to medical treatment or those who develop colitis-associated colorectal dysplasia or cancer, still require restorative proctocolectomy. The development of novel drugs and improvement of the treatment strategy by implementing personalized medicine are warranted to achieve optimal disease control. However, delineating the aetiology of UC is necessary to ultimately achieve disease cure. ? 2020, Springer Nature Limited. | - |
dc.language | en-US | - |
dc.relation.ispartof | Nature Reviews Disease Primers volume | - |
dc.subject.classification | [SDGs]SDG3 | - |
dc.subject.other | acetylsalicylic acid; adalimumab; azathioprine; biological marker; corticosteroid; golimumab; infliximab; interleukin 23; interleukin 9; Janus kinase inhibitor; mercaptopurine; methotrexate; microRNA; tofacitinib; ustekinumab; vedolizumab; Article; artificial intelligence; cancer risk; clinical practice; colorectal cancer; differential diagnosis; disability; disease severity; echography; endoscopy; extracellular trap; health; heredity; histopathology; homeostasis; human; immune response; intestine function; lamina propria; medical history; nonhuman; pathophysiology; patient care; personalized medicine; priority journal; quality of life; risk factor; screening; T lymphocyte; ulcerative colitis; global health; mass screening; procedures; ulcerative colitis; Colitis, Ulcerative; Global Health; Humans; Mass Screening; Risk Factors | - |
dc.title | Ulcerative colitis | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.1038/s41572-020-0205-x | - |
dc.relation.journalvolume | 6 | - |
dc.relation.journalissue | 74 | - |
item.fulltext | no fulltext | - |
item.grantfulltext | none | - |
item.openairetype | journal article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.orcid | 0000-0002-5017-5840 | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。